Unknown

Dataset Information

0

Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.


ABSTRACT: Chimeric antigen receptor (CAR) T cells have radically improved the treatment of B cell-derived malignancies by targeting CD19. The success has not yet expanded to treat acute myeloid leukemia (AML). We developed a Sequentially Tumor-Selected Antibody and Antigen Retrieval (STAR) system to rapidly isolate multiple nanobodies (Nbs) that preferentially bind AML cells and empower CAR T cells with anti-AML efficacy. STAR-isolated Nb157 specifically bound CD13, which is highly expressed in AML cells, and CD13 CAR T cells potently eliminated AML in vitro and in vivo. CAR T cells bispecific for CD13 and TIM3, which are upregulated in AML leukemia stem cells, eradicated patient-derived AML, with much reduced toxicity to human bone marrow stem cells and peripheral myeloid cells in mouse models, highlighting a promising approach for developing effective AML CAR T cell therapy.

SUBMITTER: He X 

PROVIDER: S-EPMC7059518 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.

He Xin X   Feng Zijie Z   Ma Jian J   Ling Sunbin S   Cao Yan Y   Gurung Buddha B   Wu Yuan Y   Katona Bryson W BW   O'Dwyer Kienan P KP   Siegel Don L DL   June Carl H CH   Hua Xianxin X  

Blood 20200301 10


Chimeric antigen receptor (CAR) T cells have radically improved the treatment of B cell-derived malignancies by targeting CD19. The success has not yet expanded to treat acute myeloid leukemia (AML). We developed a Sequentially Tumor-Selected Antibody and Antigen Retrieval (STAR) system to rapidly isolate multiple nanobodies (Nbs) that preferentially bind AML cells and empower CAR T cells with anti-AML efficacy. STAR-isolated Nb157 specifically bound CD13, which is highly expressed in AML cells,  ...[more]

Similar Datasets

| S-EPMC9387679 | biostudies-literature
| S-EPMC10424000 | biostudies-literature
| S-EPMC5386336 | biostudies-literature
| S-EPMC9950117 | biostudies-literature
| S-EPMC9050731 | biostudies-literature
| S-EPMC9007937 | biostudies-literature
| S-EPMC8010175 | biostudies-literature
| S-EPMC6295344 | biostudies-literature
| S-EPMC5761206 | biostudies-literature
| S-EPMC8201025 | biostudies-literature